Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
Recro Pharma reports 2018 executive compensation
By ExecPay News
Published: March 20, 2019
Recro Pharma reported fiscal year 2018 executive compensation information on March 20, 2019.
In 2018, three executives at Recro Pharma received on average a compensation package of $1.5M, a 4% increase compared to previous year.
Average pay of disclosed executives at Recro Pharma
Gerri Henwood, Chief Executive Officer, received $2.4M in total, which increased by 16% compared to 2017. 42% of Henwood's compensation, or $1M, was in stock awards. Henwood also received $184K in non-equity incentive plan, $600K in option awards, $599K in salary, as well as $37K in other compensation.
Michael Celano, Chief Operating Officer, received a compensation package of $1.2M, which increased by 21% compared to previous year. 35% of the compensation package, or $415K, was in salary.
Ryan Lake, Chief Financial Officer, earned $784K in 2018.
Related executives
You may also like
Source: SEC filing on March 20, 2019.